Ultrasound imaging and on-demand therapy of peripheral arterial diseases using H2O2-Activated bubble generating anti-inflammatory polymer particles

Biomaterials. 2018 Oct:179:175-185. doi: 10.1016/j.biomaterials.2018.07.003. Epub 2018 Jul 2.

Abstract

Muscles of peripheral artery disease (PAD) patients are under oxidative stress associated with a significantly elevated level of reactive oxygen species (ROS) including hydrogen peroxide (H2O2). Curcumin is a major active constituent of turmeric and is well known for its highly potent antioxidant, anti-inflammatory and angiogenic effects. We previously reported antioxidant vanillyl alcohol-incorporated copolyoxalate (PVAX) which is designed to rapidly scavenge H2O2 and release bioactive vanillyl alcohol and CO2 in a H2O2-triggered manner. In this work, we developed curcumin-loaded PVAX (CUR-PVAX) nanoparticles as contrast-enhanced ultrasound imaging agents as well as on-demand therapeutic agents for ischemic injuries based on the hypothesis that PVAX nanoparticles generate echogenic CO2 bubbles through H2O2-triggered oxidation of peroxalate esters and the merger of curcumin and PVAX exerts H2O2-activatable synergistic therapeutic actions. CUR-PVAX nanoparticles also displayed the drastic ultrasound signal in ischemic areas by generating CO2 bubbles. CUR-PVAX nanoparticles exhibited significantly higher antioxidant and anti-inflammatory activities than empty PVAX nanoparticles and equivalent curcumin in vascular endothelial cells. A mouse model of ischemic injury was used to evaluate the potential of CUR-PVAX nanoparticles as ultrasound imaging agents and on-demand therapeutic agents. CUR-PVAX nanoparticles significantly suppressed the expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β). Moreover, CUR-PVAX nanoparticles significantly enhanced the level of vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule-1 (PECAM-1, also known as CD31), leading to blood perfusion into ischemic tissues. We, therefore, believe that CUR-PVAX nanoparticles hold great translational potential as novel theranostic agents for ischemic diseases such as PAD.

Keywords: Curcumin; Hydrogen peroxide; Ischemia; Peripheral arterial disease; Ultrasound imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / chemistry
  • Antioxidants / metabolism
  • Apoptosis / drug effects
  • Curcumin / therapeutic use
  • Hydrogen Peroxide / chemistry*
  • Hydrogen Peroxide / metabolism
  • Mice
  • Nanoparticles / chemistry
  • Oxidative Stress / drug effects
  • Peripheral Arterial Disease / diagnostic imaging*
  • Peripheral Arterial Disease / drug therapy
  • Peripheral Arterial Disease / metabolism*
  • Polymers / chemistry*
  • Reactive Oxygen Species / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Polymers
  • Reactive Oxygen Species
  • Hydrogen Peroxide
  • Curcumin